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Background: Celiac disease is a chronic autoimmune disorder consisting of a permanent intolerance for gluten, 
with a prevalence of 1%, for which the only treatment to date is to follow a strict gluten free diet for life. Lack 
of adherence to this treatment is related to severe health problems while compliance leads to normalization. 
Recently, self-efficacy has been associated with self-management behaviors in chronic disease and health status 
in many fields.
Aims: To construct and validate a self-administered scale to measure self-efficacy in adherence to gluten free 
diet in the different areas a patient with celiac disease must face everyday.
Material and Methods: For the validation phase, the research team aims to recruit 500 celiac individuals over 12 
years of age from primary care services and patient associations. 
The scale will be designed to explore specific self efficacy to adhere to a gluten free diet in the following areas: 
purchases, eating out, eating at home with others, travelling and at work or school. An expert panel will be 
conducted to assure quality of the items and utility of the scale. The preliminary form will be tested in as 
many pilot studies as necessary. An exploratory factor analysis will be applied to study construct validity while 
concurrent validity will be measured with the correlation coefficient between the new instrument and the 
Baessler and Schwarzer General Self Efficacy Scale. The reliability of the instrument as well as that of each 
of the factors extracted from the prior analysis will be analyzed using Cronbach’s alpha internal consistency 
coefficient. Two weeks later, the scale will be administered to, at least, one third of the sample as a retest in the 
validation process and to allow for confirmatory factor analysis.
Results: This research will design, develop and validate a questionnaire for two types of measures: A score for 
Self-Efficacy for the management of celiac disease, and a score of self-efficacy for each of the identified key 
areas. This research will result in the first scale to assess specific self efficacy while following a strict gluten 
free diet and will allow further research in the role that this expectation may play in patient´s adherence to the 
unique treatment developed to date and it may be useful in both clinical and research settings. The new scale 
will be easy to apply and it is expected to have a higher predictive value than instruments assessing general 
self-efficacy.
Conclusions: This questionnaire will be the first of its kind to determine levels of self-efficacy for adherence to 
gluten free diet and will help to the design of self-management interventions for celiac patients.
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 Antecedentes: La enfermedad celíaca es un trastorno autoinmune crónico, caracterizado por una intolerancia 
permanente al gluten, con una prevalencia del 1%, y para la que el único tratamiento hasta la fecha consiste en 
seguir una dieta estricta libre de gluten de por vida. La falta de adherencia a este tratamiento está relacionada 
con problemas de salud graves, mientras que el cumplimiento conduce a la normalización. Recientemente, la 
auto-eficacia se ha asociado con comportamientos de autogestión de las enfermedades crónicas y el estado de 
salud en muchos campos.
Objetivos: Diseñar y validar una escala para medir la auto-eficacia en la adherencia a una dieta libre de gluten en 
los diferentes ámbitos a los que se enfrentan todos los días los pacientes con enfermedad celíaca.
Material y Métodos: Para el proceso de validación, el equipo de investigación reclutará a 500 personas diagnos-
ticadas de enfermedad celíaca, de más de 12 años de edad, a partir de los servicios de atención primaria y las 
asociaciones de pacientes. Se diseñará una escala para explorar la autoeficacia específica en la adherencia a una 
dieta sin gluten en las siguientes áreas: compras, comer fuera de casa, comer en casa con otros, viajar y comer 
en el trabajo o en el colegio. Se llevará a acabo un panel de expertos para asegurar la calidad de los ítems y la 
utilidad de la escala. Se realizarán los estudios piloto que sean necesarios para su mejora y se analizará su va-
lidez de constructo mediante un análisis factorial exploratorio mientras que la validez concurrente será medida 
mediante su correlación con la adaptación española del General Self Efficacy Scale de Baessler y Schwarzer. La 
fiabilidad del instrumento, así como de cada uno de los factores, será determinada utilizando el coeficiente alfa 
de Cronbach de consistencia interna. Dos semanas más tarde, la escala será administrada a, al menos, un tercio 
de la muestra para obtener una fiabilidad test-retest y para permitir un análisis factorial confirmatorio. 
Resultados: Se espera diseñar, construir y validar un cuestionario que permita producir dos tipos de medidas: 
una valoración especifica la auto-eficacia percibida en el manejo de la enfermedad celíaca, y una valoración de la 
auto-eficacia para cada una de las áreas clave identificadas. Esta investigación proporcionará la primera escala 
para evaluar la autoeficacia específica para la adherencia a la dieta sin gluten de importante utilidad en entornos 
tanto clínicos como de investigación. Se prevé que su valor predictivo sea superior a medidas generales de la 
expectativa de autoeficacia.
Conclusiones: Este cuestionario será el primero capaz de determinar los niveles de auto-eficacia en la adheren-
cia a la dieta libre de gluten y ayudará en el diseño de intervenciones de auto-cuidado para pacientes celíacos.
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RESUMEN
Fueyo-Díaz R, Magallón-Botaya R, Sánchez-Calavera MA, Asensio-Martínez A, Gascón-Santos S. Protocol 
development for a scale to assess self-efficacy in adherence to a gluten free diet: Self-Efficacy and Celiac Disease 
Scale. Rev Esp Nutr Hum Diet. 2015; 19(3): 160 - 166. DOI: 10.14306/renhyd.19.3.152
INTRODUCTION
CITA
Celiac disease is a chronic autoimmune disorder consisting 
of a permanent intolerance for gluten, the protein found 
in cereals like wheat, barley, and rye and, most likely, 
some varieties of oats. It occurs in genetically pre-disposed 
individuals and causes a serious enteropathy of the mucous 
membrane of the upper small intestine, so hindering the 
proper absorption of nutrients1. It is considered to be the 
most common of the chronic inflammatory intestinal 
illnesses. Many studies report a prevalence for celiac disease 
in the United States and Europe of between 1:67 and 1:2502, 
with a prevalence of 1% being widely accepted3. However, due 
to a lack of awareness regarding the wide variety of clinical 
symptoms, its diagnosis is considered to be undervalued 
by a ratio of 1:7 of diagnosed to undiagnosed cases4. The 
female-male proportion is 2:15.
Today, celiac disease is considered to be a systemic illness 
and, therefore, if it is not treated, it may result in a spectrum 
of gastrointestinal and nutritional problems, osteoporosis, 
infertility, in both men and women, or malignancy2. 
Currently, the only valid treatment is to maintain a strict 
gluten free diet for life.
The clinical characteristics of celiac disease differ 
considerably based on the age of onset of the illness. These 
characteristics are much more evident when onset occurs 
in children. At other life stages, such as adolescence or 
adulthood, extra-intestinal symptoms tend to predominate, 
leading the patient to search for a diagnosis1.
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not some ingredients may contain gluten, changes in 
product composition, etc. 
2- Traveling: celiacs may find difficulties when traveling, 
eating in trains or airplanes, handling their diet in a 
different language or with different cultural customs. 
3- Eating with others at home: this area deals with 
correcting risky behavior partaken by others, 
identifying oneself as a celiac, avoiding seeming rude 
when refusing food offered by others, etc. 
4- Eating outside the home: eating outside home is one 
of the major challenges for individuals suffering from 
celiac disease. In this case, along with self-efficacy 
for identifying oneself as a celiac, other aspects are 
relevant, including how to reject unsafe dishes, eating 
food brought from home at the restaurant, etc. 
5- Eating at work or at school: in this area, levels of self-
efficacy for participating in social situations at work 
such as company celebrations or events at school may 
play an important role.
These problems lead to negative emotions, affect 
relationships and lead to difficulties in daily life (Figure 1).
Few studies have sought to determine the safety threshold 
for gluten consumption that may be tolerated by individuals 
suffering from celiac disease; so further research is needed 
on this issue. Catassi established the maximum tolerable 
daily dose for celiac patients at 50mg/day3. This and other 
studies have led the European Union, under Commission 
Regulation (EC) Nº 41/2009, to restrict “gluten free” 
products labeling to products with less than 20mg/kg6. This 
shows the scope of the problem for individuals suffering 
from celiac disease in the management of their daily lives; 
it is not only a medical problem but also a social problem, 
as celiac patients need to be always on the alert to adhere 
to their gluten free diet. Despite the benefits of a gluten 
free diet, strict adherence is estimated to be only 45-80% 
in adults2. Therefore, further research to investigate the 
underlying factors for effective adherence is essential.
In a study conducted via critical incident interviews 
with individuals suffering from celiac disease, Sverker7 
determined that these patients face problems mainly in the 
following five areas: 
1- Purchases: the celiac patient frequently faces 
uncertainty regarding labeling issues, whether or 
Figure 1. Problems experienced in the daily lives of men and women suffering from celiac disease7.
Areas where the problems where experienced
Food situations at 
work (n=53)
Purchases 
(n=10)
Travel (n=19)
Meals with other 
people at home 
(n=36)
Meals with others 
outside the home 
(n=77)
Lived experiences of problems in everyday life (n=195)
Emotions
• Isolation
• Shame
• Fear of becoming 
contaminated by gluten
• Worries about being a bother
Relationships
• Unwanted visibility
• Neglect
• Being forgotten
• Disclosure avoidance
• Risk taking
Managemet of daily life
• Restricted product choise
• Double work
• Constanly being on call
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education is completed and the student enters high school 
institutions.
During the validation study, the scale will be administered 
to 500 participants from various Spanish Autonomous 
Communities. As the total diagnosed celiac population 
in Spain remains unknown, this sample size is estimated 
sufficient according to the objective and methodology of this 
research. Participants will be presented with an informative 
sheet on the project as well as an informed consent form. 
The questionnaire will be answered anonymously, using a 
six digit code, and sent back to the research team. 
Validation process and statistical analysis methods
Scale design: A preliminary questionnaire will be created 
based on the Spanish adaptation of Baessler and Schwarzer 
of the GSE19 on the adherence to a strict gluten-free diet for 
each of the areas identified by Sverker following, Bandura´s 
recommendations for the creation of self-efficacy scales.
A validation process for this self-administered questionnaire 
has been designed through a series of phases (Figure 2).
The pre-validation questionnaire (based on the Spanish 
adaptation of Baessler and Schwarzer of the GSE)19 will 
contain less than 80 questions, divided into the five different 
areas identified by Sverker and a section of demographic 
questions.
The scale will give a score for Self-Efficacy for the 
management of celiac disease consisting of the average 
of the scores from all of the questions; and a score of self-
efficacy for each of the identified areas.
Preliminary testing: To assess face and content validity, 
the draft will be analyzed and improved by an expert panel 
made up of university lecturers, physicians, psychologists, 
and association dietitians for their comments. Next, it will 
be trialed in as many pilot studies as necessary in order to 
create a pre-validation draft. 
It will be applied to an initial pilot group of 20 patients. The 
scale will be modified based on this initial pilot study and 
it will be tested in a second pilot until consensus about the 
quality of the questionnaire is reached. 
During expert panel and the pilot studies participants will 
be asked to answer, after examining the draft, a series of 
questions on the quality of the designed scale, grouped into 
five dimensions: appropriateness, attempting to determine 
whether or not the scale complies with the pursued 
objectives; ease: concerns the difficulty of questionnaire 
completion; applicability: whether or not the questionnaire 
reflects and evaluates the subject’s personal circumstances; 
In the frame of the Social Cognitive Theory, Bandura defines 
self-efficacy as the judgment of one’s ability to organize and 
execute given types of performances8. Self-efficacy has been 
associated with self-management behaviors9, and health 
status in many fields, such as arthritis10, physical activity11, 
multiple sclerosis12, or tobacco dependence13, and in many 
countries14.
Recently self-efficacy questionnaires and scales have been 
developed for many chronic disorders such as alcoholism15, 
multiple sclerosis16 or those developed by Bandura for 
eating habits, pain management or regulating exercise17. 
Even though Bandura suggests that self-efficacy beliefs 
tend to be specific and deeply influenced by the situation, 
Schwarzer18 has developed the General Self-Efficacy Scale 
(GSE), a 10-item scale to assess general self-efficacy rapidly. 
As this scale has good validity and reliability it may be useful 
for research purposes but lack predictive value in certain 
situations where a more specific self-efficacy needs to be 
assessed.
To date, no scale has been developed for determining self-
efficacy levels in celiac patients as an important factor in 
following a gluten free diet while facing the challenges 
arising during the daily management of their illness.
The main objective of this study is to design and validate 
a scale that permits the determination of levels of self-
efficacy in individuals suffering from celiac disease in the 
maintenance of a strict gluten free diet by examining the 
five relevant problem areas identified by Sverker.
The ultimate goal is the easy detection of patients that may 
benefit from educational interventions to increase their 
perceived self-efficacy levels for adherence to a gluten free 
diet and, therefore, to improve, not only their health, but 
also their quality of life by empowering them to participate, 
due to their feeling lower anxiety, in new activities.
It is hypothesized that the new scale, once validated, will 
predict adherence to a gluten free diet and quality of life in 
celiac patients better than the GSE.
Participants and sample size
The study population will consist of individuals affected by 
celiac disease who must follow a strict gluten free diet for 
life, based on physician’s instructions. When considering the 
appropriate age range for which the scale was designed, a 
minimum was established at 12 years of age, when primary 
MATERIAL AND METHODS
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using a scale ranging from 0 to 10, evaluating the degree 
of self-efficacy that they experience in each of the proposed 
situations. These questions should be answered on a scale 
ranging from 0 (cannot do at all) to 10 (highly certain can 
do).
In order to analyze concurrent validity, this questionnaire 
will be applied along with the Spanish adaptation of the 
General Self-Efficacy Scale, which will be used for correlation 
analysis during the validation process. In this case, a Likert 
scale of 4 original points will be presented for 1=not at all 
true, 2=hardly true, 3=moderately true, 4=exactly true. This 
scale has already been validated in Spanish19.
In addition to these questions and in order to explore 
differences in specific self efficacy when following a 
gluten free diet, other socio-demographic variables will 
be incorporated, including: place of residence, date of 
completion, if the participant should follow a gluten free 
amplitude: referring to the degree to which all of the 
important aspects are covered; universality: referring to the 
degree to which the questionnaire can be generalized to 
different subjects and to similar issues.
These questions will be answered using a scale from 1 
(completely disagree) to 5 (totally agree). Three additional 
questions are added: one regarding a general evaluation 
of the quality of the questionnaire, a second question on 
the time needed for completion and a last one catering 
for comments. Comments from experts will help to add, 
eliminate or clarify items for the validation study.
After reaching consensus, the research team will start with 
the validation study of the scale. This final version is expected 
be reduced to the 40-50 most significant items distributed 
in the five areas identified by Sverker.
Validation process: Participants will fill out the scale, in 
digital or paper format, in which they will have to answer 
Figure 2. Self-Efficacy and Celiac Disease Scale validation process. 
Design ECA Scale
Pilot study 1 (n=20)
Pilot study 2 (n=20)
Pilot study n (n=20)
ECA Scale Prevalidation draft
Validation of ECA Scale (n=500)
Statistical analysis
Final ECA Scale
Application of ECA in Spanish celiac study
Construct Validity: Exploratory
Factor Analysis
Instrument reliability: Cronbach 
Coefficient for internal 
consistency
Test-Retest Reliability:
Confirmatory Factor Analysis:
Correlation coefficients
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This questionnaire will allow the fast assessment of the 
celiac patient´s self-efficacy for each of the areas identified: 
purchases, eating with others at home, eating out with 
others, traveling and eating at work or school. 
DISCUSSION AND CONCLUSIONS
The aim of this study is the design and validation of a 
scale that will serve to determine the levels of self-efficacy 
perceived by individuals suffering from celiac disease who 
have been prescribed a strict gluten free diet in the main 
areas of their life where they may face problems.
Bandura defines the expectation of self-efficacy as the “belief 
in one´s capability to organize and execute the courses of action 
required to produce given attainments”22, clearly distinguishing 
between the perceived self-efficacy and other types of 
expectations, such as outcome expectations. Therefore, this 
scale will not seek to examine the feelings or motivations for 
following a gluten free diet, but the individual’s confidence 
in following a gluten free diet. Elsewhere, Bandura defined 
the self-efficacy belief as a specific expectation as opposed 
to a general expectation and therefore, this scale does not 
only aim to offer a measure of self-efficacy in following a 
gluten free diet, but also to explore its level for the different 
areas. 
Theoretically speaking, this study is based on the Bandura´s 
Social Cognitive Theory and Schwarzer´s HAPA model23 to 
serve as an initial step in the future design of educational 
self-management programs for the illness similar to those 
developed by Kate Lorig24 of Stanford University or van 
Puffelen of the Netherlands Institute for Health Services 
Research25.
This scale (Self-Efficacy and Celiac Disease Scale), therefore, 
will seek to examine the levels of self-efficacy of the celiac 
patients with regard to the areas determined by Sverker, 
which include: eating at work, purchases, traveling, eating 
out with others and eating at home with others.
This instrument will allow for future exploration of self-
efficacy expectation and its relationship with these variables 
and the perceived quality of life and so facilitate the design 
of self-management programs for celiac patients. This final 
scale will be applied to the celiac population of Spain as part 
of subsequent research.
Finally, it is also expected that this scale will be easily 
adaptable to other individuals suffering from illnesses 
with dietary restrictions and will foster the development of 
diet for life based on physician’s prescription, reasons for 
the diet, year of diagnosis, current age, gender, and patient 
association membership (if any).
Statistical analysis methods: Construct validity will be 
analyzed with exploratory factorial analysis using the main 
components method for factor extraction and varimax 
rotation to generate the final solution and to associate each 
of the questions in the questionnaire to its corresponding 
factor. The appropriateness of the factorial model will 
be evaluated using the KMO (Kaiser-Meyer-Olkin index of 
sampling adequacy) and Bartlett’s sphericity test20. KMO 
values above 0.75 will be expected.
The internal consistency of the instrument, as well as that 
of each of the factors extracted from the prior analysis, will 
be analyzed using Cronbach’s alpha coefficient. Similarly, 
the test-retest reliability will be examined using the non-
parametric correlation coefficients of Spearman’s rho for 
numeric variables or with Kendall’s Tau-b coefficient for 
qualitative or ordinal variables. Likewise, the questionnaire’s 
coefficient of intraclass correlation will be extracted21. Values 
above 0.65 will be accepted. Concurrent validity will be 
measured using Spearman´s rho coeficient with the General 
Self Efficacy Scale and positive and significant values are 
expected .
Two weeks later, the scale will be administered to at least 
one third of the sample as a retest in the validation process 
and to allow for confirmatory factor analysis.
Version 21 of the SPSS statistics program will be used and 
0.05 will be considered to be statistically significant for all 
analysis. 
RESULTS
 
This research will result in the first scale to assess specific self 
efficacy while following a strict gluten free diet and will allow 
further research in the role that this expectation may play in 
patient´s adherence to the unique treatment developed to 
date.
The research team intends to develop an easily applicable 
instrument, which can be completed in less than 15 minutes, 
which will give the degree of confidence of an individual 
diagnosed with celiac disease to follow a gluten free diet 
for life. The new specific scale is expected to have a higher 
predictive value than instruments assessing general self-
efficacy.
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